MALIGHETTI, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 281
NA - Nord America 103
AS - Asia 89
SA - Sud America 5
Totale 478
Nazione #
IT - Italia 147
US - Stati Uniti d'America 103
IE - Irlanda 44
SG - Singapore 42
DE - Germania 35
HK - Hong Kong 24
RU - Federazione Russa 23
CN - Cina 10
FI - Finlandia 8
ID - Indonesia 8
FR - Francia 5
GB - Regno Unito 5
PE - Perù 5
SE - Svezia 5
IN - India 4
CH - Svizzera 2
MK - Macedonia 2
NL - Olanda 2
CZ - Repubblica Ceca 1
KR - Corea 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 478
Città #
Dublin 43
Milan 40
Singapore 35
Frankfurt am Main 28
Hong Kong 24
New York 23
Santa Clara 12
Carate Brianza 11
Jakarta 8
Cesano Maderno 7
Chandler 7
Helsinki 7
Lissone 7
Monza 7
Rome 6
Ashburn 5
Lima 5
Shanghai 5
Beijing 4
Desio 4
Munich 4
Sesto San Giovanni 4
Vercelli 4
Ardea 3
Arese 3
Fairfield 3
Genoa 3
London 3
Los Angeles 3
Osio Sotto 3
Princeton 3
Alexandria 2
Bhopal 2
Boardman 2
Bolzano 2
Chicago 2
Ciserano 2
Delhi 2
Legnano 2
Mountain View 2
Pordenone 2
Rho 2
Romano d'Ezzelino 2
Salerno 2
Southwark 2
Spresiano 2
Strumica 2
Amsterdam 1
Ann Arbor 1
Bolgare 1
Bonn 1
Bonndorf 1
Bratislava 1
Breganzona 1
Brno 1
Cambridge 1
Cassano Magnago 1
Castelleone 1
Catania 1
Champigny-sur-Marne 1
Chiari 1
Cinisello Balsamo 1
Correggio 1
Corsico 1
Dalmine 1
Ithaca 1
Ivrea 1
Lappeenranta 1
Lawrence 1
Lodz 1
Marseille 1
Moscow 1
Nanjing 1
Naples 1
Nijmegen 1
Pagny-sur-Moselle 1
Palermo 1
Paris 1
San Diego 1
Seriate 1
Seveso 1
Washington 1
Wilmington 1
Écublens 1
Totale 393
Nome #
Fos rescues neuronal differentiation of sox2-deleted neural stem cells by genome-wide regulation of common sox2 and ap1(Fos-jun) target genes 86
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 78
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 63
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 53
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 52
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 52
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 43
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 40
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 38
Totale 505
Categoria #
all - tutte 3.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 0 0 7 1 2
2022/202395 8 10 8 5 6 5 1 1 16 17 11 7
2023/2024284 12 6 11 13 42 58 50 11 23 14 16 28
2024/2025116 35 80 1 0 0 0 0 0 0 0 0 0
Totale 505